Login to Your Account



Critics are circling as Astrazeneca rejects 'final bid' from Pfizer

By Nuala Moran
Staff Writer

Monday, May 19, 2014
LONDON – Astrazeneca plc's share price fell 13.45 percent to £41.74 (US$70.19) when the market opened in London on Monday after the company rejected a £55 per share "final bid" from Pfizer Inc.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription